MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer (original) (raw)
Bartel DP . (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116: 281–297. ArticleCASPubMed Google Scholar
Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E . (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell120: 21–24. ArticleCASPubMed Google Scholar
Bitomsky N, Bohm M, Klempnauer KH . (2004). Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene23: 7484–7493. ArticleCASPubMed Google Scholar
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukaemia. Proc Natl Acad Sci USA99: 15524–15529. ArticleCASPubMedPubMed Central Google Scholar
Chan JA, Krichevsky AM, Kosik KS . (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res65: 6029–6033. ArticleCASPubMed Google Scholar
Chen CZ, Li L, Lodish HF, Bartel DP . (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science303: 83–86. ArticleCASPubMed Google Scholar
Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S et al. (2003). Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. Pathology200: 640–646. ArticleCAS Google Scholar
Cmarik J, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H et al. (1999). Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA96: 14037–14042. ArticleCASPubMedPubMed Central Google Scholar
Doench JG, Sharp PA . (2004). Specificity of microRNA target selection in translational repression. Genes & Dev18: 504–511. ArticleCAS Google Scholar
Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M . (2006). S6K1- and _beta_TRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science314: 467–471. ArticleCASPubMed Google Scholar
Esquela-Kerscher A, Slack FJ . (2006). Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer6: 259–269. ArticleCASPubMed Google Scholar
Göke R, Gregel C, Göke A, Arnold R, Schmidt H, Lankat-Buttgereit B . (2004). Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann NY Acad Sci1014: 220–222. ArticlePubMed Google Scholar
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res65: 7065–7070. ArticleCASPubMed Google Scholar
Jansen AP, Camalier C, Colburn NH . (2005). Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res65: 6034–6041. ArticleCASPubMed Google Scholar
Kang M, Ahn HS, Lee JY, Matsuhashi S, Park WY . (2002). Up-regulation of PDCD4 in senescent human diploid fibroblasts. Biochem Biophys Res Commun293: 617–621. ArticleCASPubMed Google Scholar
Lankat-Buttgereit B, Gregel C, Knolle A, Hasilik A, Arnold R, Goke R . (2004). Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol Cell Endocrinol214: 149–153. ArticleCASPubMed Google Scholar
Leupold JH, Yang H-S, Colburn NH, Asangani I, Post S, Allgayer H . (2007). Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene26: 4550–4562. ArticleCASPubMed Google Scholar
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature425: 834–838. Article Google Scholar
Meister G, Landthaler M, Dorsett Y, Tuschl T . (2004). Sequence-specific inhibition of microRNA and siRNA-induced RNA silencing. RNA10: 544–550. ArticleCASPubMedPubMed Central Google Scholar
Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT et al. (2006). Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology130: 2113–2129. ArticleCASPubMed Google Scholar
Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH et al. (2007). Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer110: 1697–1707. ArticleCASPubMed Google Scholar
Onishi Y, Hashimoto S, Kizaki H . (1998). Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene215: 453–459. ArticleCASPubMed Google Scholar
Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y . (2005). Akt Phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res65: 11282–11286. ArticleCASPubMed Google Scholar
Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E et al. (2005). Inhibition of translational initiation by let-7 microRNA in human cells. Science309: 1573–1576. ArticleCASPubMed Google Scholar
Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S et al. (2006). MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol24: 4677–4684. ArticleCASPubMed Google Scholar
Schlichter U, Burk O, Worpenberg S, Klempnauer KH . (2001). The chicken Pdcd4 gene is regulated by v-Myb. Oncogene20: 669–676. Article Google Scholar
Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T . (1995). Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene166: 297–301. ArticleCASPubMed Google Scholar
Si M-L, Zhu S, Wu H, Lu Z, Wu F, Mo YY . (2007). miR-21-mediated tumor growth. Oncogene26: 2799–2803. ArticleCASPubMed Google Scholar
Yang H, Cho M, Zakowicz H, Hegamyer G, Sonenberg N, Colburn NH . (2004). A Novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Bio24: 3894–3906. ArticleCAS Google Scholar
Yang H, Knies J, Stark C, Colburn NH . (2003). Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene22: 3712–3720. ArticleCASPubMed Google Scholar
Yang H, Matthews C, Clair T, Wang Q, Baker AR, Li CC et al. (2006). Tumorigenesis suppressor Pdcd4 downregulates MAP4K1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol26: 1297–1306. ArticlePubMedPubMed Central Google Scholar
Zakowicz H, Yang H, Stark C, Wlodawer A, Laronde-Leblanc N, Colburn NH . (2005). Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA11: 261–274. ArticleCASPubMedPubMed Central Google Scholar
Zamore PD, Haley B . (2005). Ribo-gnome: the big world of small RNAs. Science309: 1519–1524. ArticleCASPubMed Google Scholar
Zhang Z, DuBois R . (2001). Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene20: 4450–4456. ArticleCASPubMed Google Scholar
Zhu S, Si M-L, Wu H, Mo YY . (2007). MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem282: 14328–14336. ArticleCASPubMed Google Scholar
Zijlstra A, Mellor R, Panzarella G, Aimes RT, Hooper JD, Marchenko ND et al. (2002). A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res62: 7083–7092. CASPubMed Google Scholar